Abstract:microRNAs (miRNAs) play an important role in regulating normal organ physiology and development. Many miRNAs show spatially and temporally restricted expression patterns during embryogenesis and organogenesis. This study aimed to characterize the miRNA profile of the fetal mouse heart at 4 key time-points [embryonic day (E)12.5, E14.5, E16.5 and E18.5] in its development, by performing a sequencing by oligonucleotide ligation and detection (SOLiD) miRNA screen. The 4 time-points were designated as groups M1 (E18.5), M2 (E16.5), M3 (E14.5) and M4 (E12.5). miRNAs found to have consistent fold-changes of >2.0) between the 4 time-points were selected for further analysis. Ten miRNAs (mmu-miR-23b, mmu-miR-24, mmu-miR-23a, mmu-miR-375, mmu-miR-29a, mmu-miR-93, mmu-miR-21, mmu-miR-25, mmu-let-7b and mmu-miR-27b) that were the most highly expressed in the 4 groups, including the percentage >1% of total read counts, were identified. No miRNA was consistently downregulated or upregulated. There were 16 differentially expressed miRNAs between the later development group (M1+M2) and the early development group (M3+M4), which were validated by quantitative real-time PCR. Several members of the let-7 miRNA cluster (mmu-let-7a/7d/7e/7f) were upregulated in the later development group compared with the early development group. A network analysis of the predicted targets of mmu-let-7a/7d/7e/7f identified 5 target genes (FOXP1, TBX5, HAND1, AKT2 and PPARGC1A), known to be involved in cardiac development. Therefore, this study identified several miRNAs that are abundantly expressed in the developing heart, several of which are differentially expressed in the 4 time-points studied. Findings of this analysis may thus clarify the mechanisms of normal heart development and provide a physiological basis for future studies on congenital heart disease.

Micrornas in Cardiovascular Development

Regulation of Cardiovascular Development, Function and Hypertension by Micrornas

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

Role of Specific Micrornas for Endothelial Function and Angiogenesis

MicroRNAs: novel regulators in cardiac development and disease

Small Molecules, Big Effects: the Role of Micrornas in Regulation of Cardiomyocyte Death

miRNAs in Heart Development and Disease

A MicroRNA Perspective on Cardiovascular Development and Diseases: An Update

Role of microRNA in cardiovascular pathophysiology

Dgcr8 Deletion in the Primitive Heart Uncovered Novel Microrna Regulating the Balance of Cardiac-Vascular Gene Program.

microRNA EXPRESSION PROFILING OF CARDIAC TISSUE DURING FETAL DEVELOPMENT 1251 vital role by regulating heart gene expression in heart

Dynamic Microrna Expression Programs During Cardiac Differentiation of Human Embryonic Stem Cells Role for Mir-499

Microrna-34a: Role In Cancer And Cardiovascular Disease

Microrna Expression Profiling of Heart Tissue During Fetal Development

Dysregulated Expression of Micrornas and Mrnas in Myocardial Infarction.

Microrna Expression Profiling of the Developing Mouse Heart.

Role and mechanism of miRNA in cardiac microvascular endothelial cells in cardiovascular diseases

Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2

Function of Micrornas in Development of Immune System and in Regulation of Immune Response

Elevated Microrna-187 Causes Cardiac Endothelial Dysplasia to Promote Congenital Heart Disease Through Inhibition of NIPBL

Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease